How halogen substitutions steer pharmacological properties of a molecule – development of antidotes for organophosphorus poisoning (CROSBI ID 706561)
Prilog sa skupa u časopisu | sažetak izlaganja sa skupa | međunarodna recenzija
Podaci o odgovornosti
Zorbaz, Tamara ; Žunec, Suzana ; Zandona, Antonio ; Katalinić, Maja ; Musilek, Kamil ; Kovarik, Zrinka
engleski
How halogen substitutions steer pharmacological properties of a molecule – development of antidotes for organophosphorus poisoning
Organophosphorus compounds (OPs) are used as pesticides or misused as chemical warfare nerve agents because they irreversibly inhibit acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) that leads to the accumulation of acetylcholine in the synapses of central and peripheral nervous system and to a lifethreatening cholinergic crisis. The reactivation of inhibited cholinesterases by oximes in combination with antimuscarinic and anticonvulsive drugs is crucial in the treatment of OP poisoning. Oximes used in medical practice have a permanently charged pyridinium ring and cross the bloodbrain barrier (BBB) poorly. However, their BBB penetration rate could be improved by the addition of a halogen substituent that increases lipophilicity. Structures of efficient bispyridinium oxime reactivators that differ in the linker between the rings (propane, butane, butene)1 were the basis for the synthesis of analogues with chlorine2, 3 or fluorine atoms. Using biochemical techniques, we tested the analogues and observed specific patterns in their interaction with AChE and BChE (pharmacological targets) and in antioxidative potential of oximes (possible supplementary pharmacological mechanism) based on the linker and substituents. Moreover, the structural differences of oximes were reflected in their cytotoxicity on neuroblastoma cell line. Our results highlighted dichlorinated bispyridinium oxime with propane linker as the best candidate for antidotal treatment after OP poisoning due to its high reactivation potential and no cytotoxic effects at pharmacologically relevant concentrations. Acknowledgement: Supported by the Croatian Science Foundation (HrZZIP2018017683, HrZZUIP2017057260). 1Kuca et al. JEIMC, 2003, 18 (6), 529−35. 2Zorbaz et al., JMC 2018, 61(23), 10753–66. 3Zorbaz et al., CBI, 2019, 307, 1620.
organophosphates, nerve agents, oxime antidotes, halogens, chlor, fluor
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
Podaci o prilogu
200-200.
2021.
nije evidentirano
objavljeno
10.1002/2211-5463.13205
Podaci o matičnoj publikaciji
Podaci o skupu
45th FEBS Congress: Molecules of Life: Towards New Horizons (FEBS 2021)
poster
03.07.2021-08.07.2021
Ljubljana, Slovenija